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Purpose
Juvenile idiopathic arthritis (JIA) is the most common
rheumatic disease in children. During the last decade
international consensus on the ILAR (International League
Against Rheumatism) classification of this heterogeneous
group of chronic childhood arthritis has been reached.
In an era of modern medical treatment, epidemiologic stu-
dies on outcome in unselected cohorts of children with
JIA are important. The aim of the study was to describe
disease characteristics, ILAR categories and remission sta-
tus during the first eight years after disease onset in a
cohort of Nordic children with JIA in a population-based
setting.
Methods
Consecutive cases of JIA from defined geographical areas
of Denmark, Finland, Sweden and Norway with disease
onset in 1997 to 2000 were included. The incidence of JIA
in the study area in 1997 - 98 was 15 per 100 000/ year.
The study aimed to be as close to population-based as
possible. JIA categories were determined according to the
ILAR criteria at onset and during disease course up to ten
years after onset. Clinical data and disease activity were
registered by a set protocol at regular follow-up visits.
Results
Of 500 included children, 440 (88%) had a follow-up visit
seven years or more after disease onset (median 96
months, range 84-147). The number of visits varied
between 2 -10 (median 5). Among the 440 children fol-
lowed, 66% were female, median age at onset was 6 years
and 51% were oligoarticular at 6 months. Extended dis-
ease course with more than four joints involved devel-
oped in 34.8% of the children with oligoarticular onset.
During the disease course, additional changes in ILAR
categories were seen in 10.5% of the children. Uveitis
developed in 88 (20%). Synthetic and/or biologic
DMARDs were reported to be used in 254 (58%) children
during the disease course. At the last follow-up, 42% of
the children were in remission off medication, 9% were
in remission on medication and 49% were not in
remission.
Conclusion
In this prospective, longitudinal study of JIA in a popula-
tion-based setting, ongoing disease was evident in a major-
ity of the children, and changes in ILAR categories
occurred during disease course. The present results under-
line the need to identify early predictors of outcome, to
further improve therapy and to continue long-term
follow-up of children with JIA.
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